Cargando…
Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial
BACKGROUND: Remimazolam besylate is a newer benzodiazepine with characteristics of quick onset of effects, short maintenance and recovery times without accumulation in tissues. This trial was conducted to confirm the efficacy and safety of remimazolam besylate versus propofol during hysteroscopy. ME...
Autores principales: | Zhang, Xiaoqiang, Li, Shuang, Liu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135983/ https://www.ncbi.nlm.nih.gov/pubmed/34016045 http://dx.doi.org/10.1186/s12871-021-01373-y |
Ejemplares similares
-
Correction to: Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial
por: Zhang, Xiaoqiang, et al.
Publicado: (2021) -
Remimazolam-remifentanil causes less postoperative nausea and vomiting than remimazolam-alfentanil during hysteroscopy: a single-centre randomized controlled trial
por: Zhang, Xiaoqiang, et al.
Publicado: (2023) -
Remimazolam Compared to Propofol During Hysteroscopy: A Safety and Efficacy Analysis
por: Fan, Shunyi, et al.
Publicado: (2023) -
Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study
por: Tang, Yun, et al.
Publicado: (2023) -
Remimazolam Tosylate Combined with Low-Dose Propofol Improves Sedation and Safety in Hysteroscopy
por: Zhang, Fan, et al.
Publicado: (2022)